Received May 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC15 | PNEUMO (VAXNEUVANCE) | MERCK & CO. INC. | 2 | Y010035 | IM / RL |
Following the second dose of Vaxneuvance, Patient had 4 days of decreased activity, decreased smiling and social responsiveness, parents described him as "just zoned out". He has never had this reaction with other vaccines.
None
None
Baby D drops
None
None